Journal of Drugs in Dermatology

View more issues:

Articles in Jan-Feb, 2005 issue of Journal of Drugs in Dermatology

• ZD1839 for recurrent or metastatic squamous cell carcinoma of the skin
• Photorejuvenation of facial skin with topical 20% 5-aminolevulinic acid and intense pulsed light treatment: a split-face comparison study
  by Tina S. Alster
• MDX-010 antibody, MDX-1379 melanoma vaccine, or MDX-010/MDX-1379 combination treatment for patients with melanoma
• Leptin to treat lipodystrophy
• The safety and efficacy of clindamycin phosphate foam 1% versus clindamycin phosphate topical gel 1% for the treatment of acne vulgaris
  by Alan R. Shalita
• Multiple basal cell carcinomas in a young adult treated with imiquimod 5%: a case report and literature review
  by Akiva Bergman
• FDA plans for increased monitoring of Accutane
• Tetracycline in preventing skin rash in patients who are receiving drugs such as gefitinib and cetuximab for cancer
• Longevity of effects of injectable products for soft-tissue augmentation
  by Philip Werschler
• Simultaneous acral nodular eruption and flagellate erythema caused by bleomycin
  by Maryann Mikhail
• Hylaform Plus filler approved for facial wrinkles and folds
• Lidocaine and Epinephrine solution for iontophoretic induction of analgesia approved
• Interferon beta in treating patients with metastatic cutaneous melanoma or ocular melanoma
• Anti-CD20 in systemic lupus erythematosus
• Campath-1H for treating adult T-cell leukemia
• Innovative uses of imiquimod
  by Ronald B. Vender
• Telemedicine legal update 2004: reimbursement, the doctor-patient relationship, teleconsultations, and the legal status of digital images
  by Noah Scheinfeld
• FDA warns Remicade may be associated with increased risk of lymphoma
• To study the use of humanized CD25 in preventing the relapse of psoriasis vulgaris
• Chemical and genetic effects of the experimental anti-cancer drugs in cheek cells in cancer patients
• Porokeratosis: a solitary oral lesion
  by Matthew J. Darling
• Clindamycin foam 1% gains FDA approval for the treatment of acne vulgaris
• Gene therapy and vaccine treatment to treat metastatic melanoma
• Interleukin-7 and peptide vaccine to treat metastatic melanoma
• Skin Cancer Foundation update
• Dual wavelength laser receives FDA clearance
• Iatrogenic contact dermatitis due to propylene glycol
  by Rebecca Lu
• New drug application submitted for IV meropenem
• A multicenter, open-label study to assess the safety and efficacy of ciclopirox topical suspension 0.77% in the treatment of diaper dermatitis due to Candida albicans
  by Elizabeth Gallup
• Complete resolution of generalized lichen planus after treatment with thalidomide
  by Jennifer L. Maender
• FDA grants market approval for Captique injectable gel
• New chip implant allows for emergency retrieval of medical information
• Vaccine treatment in combination with IL-2 and treated lymphocytes for advanced melanoma
• Intravenous mepolizumab in subjects with hypereosinophilic syndromes
• A letter from the guest editor
  by Dan Siegel
• A multicenter clinical evaluation of the treatment of mild to moderate inflammatory acne vulgaris of the face with visible blue light in comparison to topical 1% clindamycin antibiotic solution
  by Michael H. Gold
• Electronic prescribing: an update
  by Mark D. Kaufmann
• Connetics submits New Drug Application for Velac
• Monoclonal antibody treatment for systemic lupus erythematosus
• Infliximab to treat non-infectious scleritis
• A dermatologist's response to the American Academy of Pediatrics guidelines on head lice
  by Craig G. Burkhart
• Online drug information for dermatology patients
  by Amanda Oakley
• Phase II randomized bilateral comparison of topical targretin gel 1% in alopecia areata
• Peptide-sensitized lymphocytes plus melanoma peptide immunization followed by IL-2 to treat patients with melanoma
• FDA grants approval for new oral solution of Levaquin
• Mechanisms of the comedolytic and anti-inflammatory properties of topical retinoids
  by Joseph B. Bikowski
• Palisaded encapsulated neuroma—a classic presentation of a commonly misdiagnosed neural tumor
  by Olga Golod
• New laser system approved for endovenous treatment of varicose veins
• Ultraviolet light therapy for systemic lupus erythematosus
• The potential utility of statin vaginal gels in the prevention of HIV transmission
  by M.R. Namazi
• Intralesional injection of 2% zinc sulfate solution in the treatment of acute old world cutaneous leishmaniasis: a randomized, double-blind, controlled clinical trial
  by Alireza Firooz
• Washington Whispers
• Aventis announces approval of extended release Allegra-D
• Radiation therapy in preventing metastatic cancer in patients who have diagnostic procedures to identify malignant mesothelioma
• Lymphocyte-depleting conditioning followed by infusion of engineered lymphocytes and vaccination to treat advanced melanoma